e-Newsletter | January / February 2021
Prostate Cancer Clinical Trials and Genetic Testing
Genetic Testing is the process of analyzing cells or tissue to look for changes in genes, chromosomes, or proteins, which could cause a disease or cancer. Genetic testing may be done on tumor tissue to help diagnose cancer, develop treatment plans, or show how well the treatment is working. Read More
Why should I get tested?

  • To look for gene mutations that suggest the possibility of cancer
  • Results can impact your treatment
  • Other family members will know their risk of prostate cancer
  • Some genetic mutations can cause cancer to be more aggressive
  • The test is easy to perform on blood, saliva or tissue samples
Clinical Trials
Genetic tests can also help find gene mutations which indicate if a patient is eligible for specific types of clinical trials. The Amplitude clinical trial is one such trial which is highlighted below. The Amplitude trial not only incorporates genetic testing, but also the PARP inhibitor Niraparib. Niraparib has received FDA approval for other types of cancers.

1 in 6 prostate cancers are caused by an inherited genetic mutation
Clinical Trial Highlights
Amplitude

The AMPLITUDE study is looking for men with newly diagnosed metastatic prostate cancer and genetic mutations in either the patient or tumor, which makes them eligible for this trial. 
APA RP

The APA RP study is looking for men with prostate cancer at high risk of metastasis and who have recently undergone or are planning to undergo radical prostatectomy (RP) surgery.
For more clinical trials Information visit:
*** Alert - Prostate Cancer Crisis ***
New Cases to Increase 30% In 2021!

Join a Special PHEN Webinar On Wed. Feb. 10th @ 6pm ET
Treatment Pathways for Prostate Cancer Patients
From initial diagnosis and all along a prostate cancer journey,
PHENPath supports patients in making informed and shared-decisions with their doctors.
PHEN Clinical Trial Rally Partners